Christopher John Kenney
Chief Medical Officer at Xenon Pharmaceuticals Inc. (XENE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $670K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 31SEC | XENEXenon Pharmaceuticals Inc. | Sell Plan | 6,368702 held (−90%) | $60.17 | $383K | -44.3% |
| Aug 31SEC | XENEXenon Pharmaceuticals Inc. | Sell Plan | 7002 held (−100%) | $60.98 | $43K | -45.1% |
| Mar 13SEC | XENEXenon Pharmaceuticals Inc. | Sell Plan | 1,4107,069 held (−17%) | $55.23 | $78K | -39.4% |
| Mar 11SEC | XENEXenon Pharmaceuticals Inc. | Sell Plan | 2,7714,729 held (−37%) | $60.11 | $167K | -44.3% |
- Sell
Chief Medical Officer Christopher John Kenney sold $383K of XENE at $60.17 — cuts the stake by 90%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Christopher John Kenney sold $43K of XENE at $60.98 — cuts the stake by 100%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Christopher John Kenney sold $78K of XENE at $55.23 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Christopher John Kenney sold $167K of XENE at $60.11 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.